论文部分内容阅读
放射性纤维蛋白原试验能准确地检出下肢深部静脉血栓,应用该技术发现急性心肌梗塞患者中的静脉血栓发生率为29%～38%。过去曾报道给急性心肌梗塞患者以足量的抗凝治疗,其静脉血栓发生率为9.4%,而每天给予1000单位肝素共二天者,其发生率为12.4%,两者无显著差异。本文再次对比对照组、小剂量肝素治疗组、以及足量肝素加苄丙酮香豆素(华法令 Warfarin)治疗组的静脉血栓发生率,同时观察心力衰竭对静脉血栓形成的影响。方法:凡急性心肌梗塞发病48小时以内,无抗凝治疗反指证者,均为本研究对象,不包括已用过抗凝治疗及有心源性休克者。在115例中有108例能完成试验观察。受试者被随机分成三组:足量抗凝治疗组(35例),先静脉给予5000单位肝素作负荷
Radiofibrinogen test can accurately detect deep venous thrombosis of lower extremities, the application of the technology found that the incidence of venous thrombosis in patients with acute myocardial infarction was 29% to 38%. It has been reported in the past that adequate venous anticoagulation was given to patients with acute myocardial infarction with a venous thromboembolic rate of 9.4%. However, the rate of venous thrombosis was 12.4% with 1000 units of heparin administered daily, with no significant difference between the two. This article again compared the control group, low-dose heparin treatment group and adequate heparin plus warfarin warfarin treatment group venous thrombosis incidence, while observing the impact of heart failure on venous thrombosis. Methods: Where the onset of acute myocardial infarction within 48 hours without anticoagulant anti-finger-pointing, are the subjects of this study, not including those who have used anticoagulant therapy and cardiogenic shock were. In 115 cases of 108 cases to complete the test observation. Subjects were randomly divided into three groups: adequate anticoagulant therapy group (35 cases), the first intravenous administration of 5000 units of heparin as a load